Skip to content
Tokyo Brief東 京 ブ リ ー フJapan's day, wrapped and delivered by morning.
Company
Companies

J-Pharma

ジェイファーマ

520A · TSE · Pharmaceutical · 1 article

Financials Company only

Ordinary profit−¥2.64bnCompany only · FY3/26

Performance over time

Ordinary profit
−¥1.08bnFY3/22
−¥1.09bnFY3/23
−¥1.64bnFY3/24
−¥1.53bnFY3/25
−¥2.64bnFY3/26
Op. cash flow
—FY3/22
—FY3/23
−¥1.41bnFY3/24
−¥1.69bnFY3/25
−¥2.25bnFY3/26

People & pay

Employees16 peopleFY3/26

Average salary¥11.2mFY3/26

Average salary is for the parent company's own employees (non-consolidated), as Japanese annual reports disclose it.

Five-year history
Five-year history
Fiscal yearOrdinary profitEPSTotal assetsNet assetsOp. cash flow
FY3/26−¥2.64bn−¥195.08¥4.76bn¥4,378m−¥2.25bn
FY3/25−¥1.53bn−¥184.05¥2.86bn¥2,378m−¥1.69bn
FY3/24−¥1.64bn−¥263.57¥1.21bn¥950m−¥1.41bn
FY3/23−¥1.09bn−¥952.74¥1.75bn¥1,408m—
FY3/22−¥1.08bn−¥974.48¥1.17bn¥994m—

Per-share figures are as each report states them: a share split is restated only for the year before it, and dividends are as paid.

Figures from annual report S100YJUW · Japan GAAP. Each figure's years come from one report's five-year summary.

Latest coverage

TSE:520A

  1. J-Pharma wins AMED backing of up to ¥1.5bn for biliary cancer trial

    J-Pharma's Phase 3 biliary cancer trial was selected for AMED support covering half of eligible costs, up to ¥1.5bn, and the company says full payment would fund Part A without new financing.

AGM votes

This season’s shareholder voting results.

1 meeting · data through

AGM votes
ProposalApprovalResultFiling
Reduction of the amounts of stated capital and capital reserves and disposal of surplusMachine translated
Original (Japanese)資本金及び資本準備金の額の減少並びに剰余金処分の件
99.05%Votes cast: 99.07%ApprovedFiled  — filing S100YO6J
Election of 4 directors (excluding audit committee directors)
Original (Japanese)取締役(監査等委員である取締役を除く。)4名選任の件
· 吉武 益広
98.20%Votes cast: 98.21%ApprovedFiled  — filing S100YO6J
Election of 4 directors (excluding audit committee directors)
Original (Japanese)取締役(監査等委員である取締役を除く。)4名選任の件
· 藤本 裕
98.96%Votes cast: 98.97%ApprovedFiled  — filing S100YO6J
Election of 4 directors (excluding audit committee directors)
Original (Japanese)取締役(監査等委員である取締役を除く。)4名選任の件
· 山本 寛
98.83%Votes cast: 98.85%ApprovedFiled  — filing S100YO6J
Election of 4 directors (excluding audit committee directors)
Original (Japanese)取締役(監査等委員である取締役を除く。)4名選任の件
· 上原 祐香
98.88%Votes cast: 98.90%ApprovedFiled  — filing S100YO6J
Matter concerning determination of remuneration for the grant of restricted stock to directors (excluding outside directors and directors who are audit and supervisory committee members).Machine translated
Original (Japanese)取締役(社外取締役及び監査等委員である取締役を除く。)に対する譲渡制限付株式の付与のための報酬決定の件
96.31%Votes cast: 96.33%ApprovedFiled  — filing S100YO6J

Approval is the ratio the company states (usually of the voting rights of shareholders present); votes cast are for ÷ (for + against + abstain).

† Percentage of votes cast; company did not state a ratio.

† Company-stated ratio differs from tallied votes.